NCT01522963View on ClinicalTrials.gov

Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Tobacco Use Disorder
Interventions
DRUG

Nicotine lozenge

A single dose of nicotine lozenge will be given at various timepoints relative to completion of a somewhat stressful task

Trial Locations (1)

55455

Clinical and Translational Sciences Institute, Minneapolis

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Minnesota

OTHER

NCT01522963 - Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms | Biotech Hunter | Biotech Hunter